Stock vs Stock Comparison

Bristol-Myers Squibb Company vs Absci Corporation

BMY wins the Tale of the Tape 6–3.

BMY$54.72
ABSI$5.94

🏆 Tale of the Tape

63
BMYABSI
14.6%Profitability (Net Margin)-4113.7%
16.0xValuation (P/E)
13.3%Efficiency (ROIC)-46.9%
9/9Health (Piotroski F)2/9
2.3Safety (Altman Z)5.1
-0.2%Growth (Rev YoY)-38.2%
0.38Risk (Sharpe 1Y)0.56
3.87xBalance Sheet (D/E)0.14x
8.43%FCF Yield-21.57%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.156
252-Day Correlation
0.125
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricBMYABSI
Market Cap$116.8B$1.1B
P/E Ratio16.0x
Forward P/E9.3x-10.6x
P/B5.82x6.10x
Dividend Yield4.41%
Beta0.262.38

Quantitative Metrics

MetricBMYABSI
DCF Fair Value$102.60
DCF Upside+76.7%
Piotroski F9/92/9
Altman Z2.295.11
Beneish M-2.73
FCF Yield8.43%-21.57%
Net Debt/EBITDA2.1x
ROIC13.3%-46.9%
WACC6.9%
ROIC – WACC6.4pp
Gross Margin71.1%
Net Margin14.6%-4113.7%
Rev Growth YoY-0.2%-38.2%
Sharpe (1Y)0.380.56
Max Drawdown 3Y-66.1%
FCF Payout Ratio39%

BMY Price

Loading chart...

ABSI Price

Loading chart...

ETF Exposure

BMY found in:

SCHD4.28%
MOAT2.70%
XLV2.26%
VHT2.00%
XPH1.81%
SPYD1.30%
VFVA0.98%
MGV0.61%
VYM0.51%
VTV0.48%
SCHV0.43%
SPYV0.42%
IWD0.33%
VONV0.30%
ESGV0.25%
RSP0.21%
SCHX0.20%
VOO0.20%
SCHB0.19%
VONE0.19%
SPY0.19%
IVV0.19%
VTI0.18%
SPTM0.18%
ITOT0.17%
QUS0.15%
URTH0.15%
SPLG0.15%
ACWI0.12%
VT0.11%
IWF0.09%
VONG0.08%
ONEO0.03%

ABSI found in:

ARKG4.81%
XBI0.32%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

BMY vs ABSI: Head-to-Head Analysis

Bristol-Myers Squibb Company (BMY) and Absci Corporation (ABSI) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, BMY leads 6–3 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, BMY generates a return on invested capital (ROIC) of 13.3% compared to ABSI's -46.9%. This suggests BMY is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between BMY and ABSI is 0.156, indicating low correlation, making them an effective diversification pair in a portfolio context.

BMY appears in 33 ETFs tracked by SecuritiesDB, while ABSI appears in 2 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, BMY or ABSI?

Our quantitative analysis compares BMY and ABSI across nine fundamental dimensions. BMY wins the Tale of the Tape 6–3. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are BMY and ABSI correlated?

The 252-day correlation between BMY and ABSI is 0.156. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.